ROCHE HOLDING LTD purchased 1.2% of their position (36.11K shares) of PANDION THERAPEUTICS, INC. on the open market
Open‑market purchase worth $650.0K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 7/23/2020ACC: 0000899243-20-020217
10% Owner
Since Jul 2020
-12.47M
Net shares
Net seller
$650.0K
Total acquired
1
Open market trades
1B · 0S
4
Total transactions
3.09M acquired · 15.55M disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+3.05M
Price / share
—
Trade value
—
% of position
New position
7/21/2020
0.00→3.05M
Common Stock
Indirect
Shares
+36.11K
Price / share
$18.00
Trade value
$650K
% of position
1.2%
7/21/2020
3.05M→3.09M
Total
Net shares
+3.09M
Net value
$650K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 7/21/2020 | C · Conversion | +3.05M | — | — | New position | 0.00 | 3.05M |
| Common Stock Indirect | 7/21/2020 | P · Purchase | +36.11K | $18.00 | $650K | 1.2% | 3.05M | 3.09M |
| Total | +3.09M | $650K | ||||||
Derivative Transactions2
Series A Preferred Stock
Indirect
Converts to
Common Stock
2.58M shares
Shares
−13.14M
Strike price
Held after
0.00
Exercisable
—
7/21/2020
Series B Preferred Stock
Indirect
Converts to
Common Stock
473.41K shares
Shares
−2.41M
Strike price
Held after
0.00
Exercisable
—
7/21/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A Preferred Stock Indirect | Common Stock2.58M shares | 7/21/2020 | C · Conversion | −13.14M | — | 0.00 | |
| Series B Preferred Stock Indirect | Common Stock473.41K shares | 7/21/2020 | C · Conversion | −2.41M | — | 0.00 |